熱門資訊> 正文

Candel Therapeutics任命Charles Schoch为首席财务官

2025-06-23 20:11

Candel Therapeutics (NASDAQ:CADL) Monday announced the appointment of Charles Schoch as Chief Financial Officer.
Schoch, who has served as interim (CFO) of Candel (NASDAQ:CADL) since January 2024, will transition to the CFO role permanently, effective immediately.

More on Candel Therapeutics

Candel Therapeutics: CAN-2409's Promising Progress Deserves An Upgrade
Candel gains after FDA RMT designation for lead asset
Candel Therapeutics GAAP EPS of $0.13
Seeking Alpha’s Quant Rating on Candel Therapeutics
Historical earnings data for Candel Therapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。